Third Circuit Court Invalidated Materiality Rule
The appellate court overturned a 30-year-old standard used in shareholder litigation cases.
Updated on Sept. 30, 2026 in Public Companies

Live Poll
Should it be easier for investors to hold companies accountable for misleading financial outlooks?
The Third Circuit Court of Appeals has invalidated a nearly 30-year-old judicial rule regarding investor materiality analysis. This decision requires a reassessment of a securities class action case against Pennsylvania-based Ocugen Inc.
Why it matters
The ruling ensures that lower courts align their materiality assessments with current US Supreme Court precedents. By removing the older circuit rule, the appellate panel has altered the legal framework for how investors prove claims that companies misled them about financial outlooks.
The invalidated judicial rule was in effect for 30 years prior to the court of appeals decision. The case involves allegations that Ocugen Inc. misled shareholders regarding its financial outlook.
The players
Third Circuit Court of Appeals
This is a federal appellate court that hears cases originating from the district courts of Pennsylvania, New Jersey, Delaware, and the US Virgin Islands.
Ocugen Inc.
This is a biotechnology company focused on developing gene therapies and vaccines for various diseases.
US District Court for the Eastern District of Pennsylvania
This is a federal trial court that handles civil and criminal litigation within a district encompassing Philadelphia and surrounding counties.
The details
The US District Court for the Eastern District of Pennsylvania originally dismissed the class action lawsuit against Ocugen Inc. based on the now-defunct materiality standard. The appellate court vacated that dismissal, finding the reliance on the older rule improper in light of modern Supreme Court guidance.
Timeline
The judicial rule regarding investor materiality was established in 1996.
The Third Circuit Court of Appeals issued its ruling on September 30, 2026.
Market Landscape
The court updated its rule to match the US Supreme Court materiality standards, which guides how lower courts evaluate investor claims. This ruling realigns regional legal practices with national mandates, ensuring consistency in how securities fraud allegations are scrutinized.
Shareholders involved in pending litigation may see their cases revived as district courts re-evaluate allegations under the new standard. This shift could impact how corporations in the biotech sector and beyond approach disclosures and transparency with their investors.
The takeaway
This decision underscores the importance of staying current with shifting Supreme Court precedents in complex business litigation. Investors should monitor how district courts apply these revised standards as they move to reconsider previously dismissed securities claims.
Further reading
For more on the current state of corporate legal challenges, visit the Public Companies section.
Live Poll
Should it be easier for investors to hold companies accountable for misleading financial outlooks?










